All In Biotech

Drug Trial Radar · NCT00002408

A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Orally Administered SP-303 for the Treatment of Diarrhea in Acquired Immunodeficiency Syndrome (AIDS) Patients

Last checked: Nov 19, 2026Latest source record: Jun 24, 2005 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

300

Actual

Start

Not stated

Primary completion

Not stated

Sponsor

Lead sponsor
Shaman PharmaceuticalsIndustry
Sponsor type
Industry
First posted
Aug 31, 2001

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Masking
Double
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To evaluate the efficacy, safety, and durability of response of SP-303 in decreasing stool weight in AIDS patients with diarrhea over 6 days of treatment.

Conditions

  • Diarrhea
  • HIV Infections

Interventions

  • CrofelemerDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

No primary outcomes listed.

Locations

36 sites in 2 countries. Site status is shown where the registry gives one.

  • Hill Top Research Ltd

    Scottsdale, Arizona

  • Phoenix Living Ctr

    Scottsdale, Arizona

  • UCLA Care Ctr

    Los Angeles, California

  • AIDS Research Ctr / Dept of Veterans Affairs

    Palo Alto, California

  • San Francisco Gen Hosp

    San Francisco, California

  • Lynn House Hospice

    West Hollywood, California

  • AIDS Research Alliance

    West Hollywood, California

  • Howard Univ

    Washington D.C., District of Columbia

  • GCRC

    Washington D.C., District of Columbia

  • Community CRI of South Florida

    Coral Gables, Florida

  • Central Florida Research Initiative

    Maitland, Florida

  • Deering Hosp

    Miami, Florida

  • Rosemont Health Care Ctr

    Orlando, Florida

  • Ctr for Quality Care

    Tampa, Florida

  • Mem Hosp of Tampa

    Tampa, Florida

  • Phillip Branchman

    Atlanta, Georgia

  • Insite Clinical Trials

    Decatur, Georgia

  • Oak Park Hosp

    Oak Park, Illinois

  • Indiana Univ Med Ctr

    Indianapolis, Indiana

  • New Orleans Pharmaceutical Research

    Kenner, Louisiana

  • Johns Hopkins Hosp

    Baltimore, Maryland

  • New England Med Ctr

    Boston, Massachusetts

  • Wayne State Univ

    Detroit, Michigan

  • Hennepin County Med Ctr

    Minneapolis, Minnesota

  • Regions Hosp

    Saint Paul, Minnesota

  • Washington Univ School of Medicine

    St Louis, Missouri

  • Brookdale Univ Hosp and Med Ctr

    Brooklyn, New York

  • Saint Vincents Hosp

    New York, New York

  • Wake Med CRI

    Raleigh, North Carolina

  • Joseph Gathe

    Houston, Texas

  • GCRC - VA Hosp

    San Antonio, Texas

  • South Texas Veterans Health Care System

    San Antonio, Texas

  • Bailey Boushay House

    Seattle, Washington

  • Rosehedge House

    Seattle, Washington

  • Hosp Regional de Ponce

    Ponce, Puerto Rico

  • Clinical Research Puerto Rico Inc

    San Juan, Puerto Rico

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.